Information about Primary Pulmonary Hypertension and other forms of Severe Pulmonary Hypertension


PPH NEWS is an education-based resource site that provides information on the health issues surrounding Primary Pulmonary Hypertension (PPH), including what it is, the symptoms, diagnoses, and treatment options.
This website also provides resource to learn more about your legal rights and remedies if you or someone you know has developed PPH due to the use of diet drugs such as Fen Phen.

Get a FREE Evaluation

Select your state to
contact a PPH Lawyer

PPH News

February 12, 2006

Antidepressants increase risk of Pulmonary Hypertension

According to a study released February 8, 2006, women who take Paxil, Zoloft, and other antidepressants late in their pregnancies are at an increased risk of delivering babies with a serious lung condition called persistent or primary pulmonary hypertension.

While this condition is commonly called primary pulmonary hypertension (PPH) in adults, the condition is given the name persistent pulmonary hypertension of the newborn (PPHN) when it affects infants. The term "persistent" is applied because it is common for infants to be born with high pressure in the lungs. Typically, this high pressure decreases in the first hours and days of life. Infants whose circulation systems are unable to adapt to breathing outside the womb have what is called persistent pulmonary hypertension of the newborn.

About one to two infants in the general population are born with primary pulmonary hypertension. Of these infants, ten to twenty percent will die. According to researchers, the risk of a newborn developing PPHN is SIX times greater for women who used an SSRI antidepressant during the third trimester, compared to those in the general population. While this risk appears to be rare, this possible antidepressant drug side effect may be significant.

While the recent study gave no clear indication that women should NOT take Paxil, Prozac, Celexa, or Zoloft during pregnancy, the New England Journal of Medicine study prompted significant concern within the FDA. The federal agency hastily called a news conference to address the results. According to an FDA spokesperson, "This appears to be a well-conducted study and we find the results to be very concerning."

Researchers at the University of California, including the lead author of the antidepressants study, Christina Chambers, pregnant women who suffer from depression or other psychological conditions need to speak with their doctors to determine the best and safest course of treatment.

Another doctor, Jennifer Woo M.D. at a New York City hospital, adds, "I think that there are a certain number of patients who have severe depression for whom SSRIs do work who need to continue them during pregnancy. Other patients with less severe depression may want to go off."

This study was published following an number of others warning of antidepressant drug side effects. A small study published just two days before in the Archives of Pediatrics and Adolescent Medicine found that newborns born to women taking SSRIs were at an increased risk of experiencing withdrawal symptoms from the drugs. A September 2005 study showed that taking Paxil in the first trimester increased the risk of birth defects. The use of SSRIs during pregnancy has also been associated with a 20 to 30 percent increased risk of "neonatal complications" which can range from jitters to breathing problems.

If you are concerned about the link between antidepressant medications and primary pulmonary hypertension, you may wish to discuss the risks and benefits of treatment with your trusted health care professional. If your child have developed PPHN, you may wish to contact a lawyer who can help protect your legal interests.

 

FREE Case Evaluation for more information.

 

Click a state below to find a PPH Lawyer in your area.

 

SELECT YOUR STATE TO CONTACT A PPH LAWYER
Alabama Alaska Arizona Arkansas
California Colorado Connecticut Delaware
Florida Georgia Hawaii Idaho
Illinois Indiana Iowa Kansas
Kentucky Louisiana Maine Maryland
Massachusetts Michigan Minnesota Mississippi
Missouri Montana Nebraska Nevada
New Hampshire New Jersey New Mexico New York
North Carolina North Dakota Ohio Oklahoma
Oregon Pennsylvania Puerto Rico Rhode Island
South Carolina South Dakota Tennessee Texas
Utah Vermont Virginia Washington
Washington DC West Virginia Wisconsin Wyoming

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

top

Home

Legal Issues

PPH FAQ's

PPH Explained

Causes

Case

Injury

Settlement

Symptoms

Diagnosing PPH

Diagnosis

Treatment

Medications

Pulmonary Hypertension

What is Fen Phen

Problems Associated
with Fen Phen

Fen Phen and PPH

Fen Phen and Heart Disease

Fen Phen/Legal Rights

PPh Lawsuits

FDA Withdrawal

News

History

Links

 

Learn More About PPH Treatments:
» Remodulin
» Flolan
» Tracleer


Patients suffering from Primary Pulmonary Hypertension (PPH) caused by Fen-Phen, Pondimin or Redux are not included in the Nationwide Class Action Settlement Agreement with American Home Products.  PPH patients must file independent lawsuits to make legal claims.  To learn your legal rights, please contact us and speak with a PPH Lawyer for lawsuit information!